Busulfan

BUSULFEX, MYLERAN

Alkylating Drug

NADAC/unit N/A

No Shortage 8 Manufacturers 8 ANDAs

Busulfan damages cancer cell DNA to prevent tumor growth.

Covered Lives

Active Shortages

2025-10-24 Discontinuation of the manufacture of the drug., Mylan Institutional, a Viatris Company

Generic Manufacturers

ACCORD HEALTHCARE INC USAAMNEAL EU LTDHOSPIRA INCMEITHEAL PHARMACEUTICALS INCMYLAN INSTITUTIONAL INCOTSUKA PHARMACEUTICAL CO LTDPHARMASCIENCE INCPRINSTON PHARMACEUTICAL INCSHILPA MEDICARE LTDWAYLIS THERAPEUTICS LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Busulfan drfinder.aiFind doctors who prescribe Busulfan rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Busulfan

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.